Ask the Expert: Avastin for Recurrent Glioblastoma Multiforme

What is Avastin?

Avastin® (Bevacizumab) is the first and only biologic treatment approved by Health Canada for recurrent glioblastoma multiforme (GBM), which offers an additional treatment option for people with the disease.

How is Avastin administered?

Avastin is given as a single agent at 10 mg/kg intravenously, once every two weeks.

How does Avastin work?

Avastin directly targets the tumour by controlling its growth and extends survival with only a limited impact on quality of life.

Is Avastin approved by Health Canada?

Health Canada approved Avastin in March 2010 as treatment for recurrent GBM.

How do patients access Avastin?

The answer to this question depends on:

  • The province in which the patient lives: In British Columbia, Saskatchewan and Manitoba, there is public access for Avastin in recurrent GBM via provincial drug plans.
  • Whether the patient has private insurance that provides coverage for Avastin.

Beyond the provinces where there is provincial coverage, access to Avastin depends on the type of private insurance coverage each patient may have (often from an employer). Once prescribed Avastin by their oncologist, a patient will contact their insurance carrier to determine coverage.

Please note, however, reimbursement via private insurance coverage is often granted on a case-by-case basis and may not be guaranteed.

There is also a Roche Patient Assistance Program (RPAP) in place to help patients access Avastin.

How do patients connect with the RPAP program?

For reimbursement navigation and coordination, financial assistance and infusion support services, patients should work with their oncologist to enrol in RPAP or call the program directly, toll-free, at 1-888-748-8926, Monday to Friday, 8:00 am to 8:00 pm Eastern Standard Time. Patients can also visit the RPAP website for more information.

Find more information about how to access Avastin

What is the most recent information about Avastin?

New research about the brain tumour treatment Bevacizumab (Avastin®) was released at the recent American Society of Clinical Oncology (ASCO) 2013 Annual Meeting. Results were presented from two recent clinical trials focused on the treatment. Read our summary of the results.

Find more information about advocacy on behalf of a patient or advocacy in support of the brain tumour community in the advocacy section of the website.
Download this information as a Brain Tumour Foundation of Canada Information Sheet (pdf)

Return to Information Sheets here.

This information is provided for information purposes only, and do not represent advice, an endorsement or a recommendation, with respect to any product, service or business, and/or the claims and properties thereof, by Brain Tumour Foundation of Canada. Always consult your health care team if you have questions about your medical care and treatments options.

Share This

Featured Story

Facing Off for Brain Tumours

Docs on Ice is a three-day hockey tournament for 900 doctors from all across Ontario. The tournament is raising funds for Brain Tumour Foundation of Canada. All funds raised through this tourment are being directed to the Canadian Brain Tumour Registry. Find out how you can help!

Learn more

Spotlight

"Thank you for giving, you are changing lives."

Amber was one of the very first people to register for......

Learn more

Give a Hug Day - March 5

“Give-a-Hug Day” stems from young brain tumour survivor Sebastian Yanquelevech’s concerns that his mother would feel upset during his...

Learn more

Upcoming Events

  • 28/Mar/2015: Awareness Display - Burlington, ON: Burlington Public Library... Learn more >
  • 29/Mar/2015: BrainWAVE ON Spring Event : The Dunfield Theatre - 46 Grand Avenue South, Cambridge ON... Learn more >
  • 29/Mar/2015: Awareness Display - Burlington, ON: Burlington Public Library... Learn more >
  • 30/Mar/2015: Greater Sudbury Support Group: Meets at Sudbury Public Library - Main Branch, 74 MacKenzie Street... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2015 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001
Imagine Canada Ethical Code